Radiosurgery has long been the
domain of neurosurgeons becauseof its
singular usefulness in the treatment of
intracranial lesions.

It’s true that some tumor types are
resistant to the radiobiological effect of
conventional radiation therapy. But they
aren’t resistant to the Cyberknife.

It’s true that some tumor types are
resistant to the radiobiological effect of
conventional radiation therapy. But they
aren’t resistant to Radiosurgical ablation

We can treat inoperable patients, shrink
tumors for less radical resections,
destroy radioresistant tumors and treat
previously treated.

Because CyberKnife is noninvasive, it can
treat patients who can’t endure surgery or
who have a high risk for postoperative
complications.

CyberKnife often is used alone to treat
these lesions but can also be combined
with surgery and other treatments to
maximize treatment benefit.

For tumor types known to have a high
likelihood of recurrence, CyberKnife’s low
cumulative exposure make it an ideal
treatment option.

While conventional radiation therapy
doesn’t do as well in the treatment of these kinds of lesions, CyberKnife’s ablative
radiation dose is quite effective.